Skip to main content
SpringerLink
Log in

Changes in Thyrotropin Binding Inhibiting Immunoglobulins (TBII) in sera of patients with Graves’ disease at the time of relapse or exacerbation

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Thyrotropin Binding Inhibiting Immunoglobulins (TBII) were measured in sera of 240 patients with Graves’ disease who were followed 0–25 yr as a cross-sectioned study (21 untreated, 189 under therapy and 30 T3-suppressible and drug-discontinued patients) by using solubilized porcine thyroid TSH receptor. Assays were performed by using 50 μl of serum. All untreated 21 patients showed positive TBII. Frequency of positive patients decreased yearly with treatment although 36% of patients remained positive after 6 yr of therapy. After that time TBII were positive in 61 % of follow-up patients and in 16 positive patients who have been treated for more than 10 yr, drug therapy could not be stopped because of recurrence. TBII were positive in 6 of 30 T3-suppressible patients. As a longitudinal study changes in TBII were studied in 10 patients at the time of relapse or exacerbation. TBII increased in parallel with increases in thyroid hormone concentrations in 3 of 10 patients. Six of the others showed earlier or later TBII increases than those in thyroid hormones. One patient did not show any change in TBII, albeit thyroid hormone concentrations were found to be increased. Our observations suggest that abnormal IgGs detected as TBII in sera of patients with Graves’ disease by the present method do not explain the occurrence of hyperthyroidism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mukhtar E.D., Smith B.R., Pyle G.A., Hall R., Vice P. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine and antithyroid drugs. Lancet 1: 713, 1975.

    Article  PubMed  CAS  Google Scholar 

  2. Shewring G., Smith B.R. An improved radioreceptor assay for TSH receptor antibodies. Clin. Endocrinol. 17: 409, 1976.

    Article  Google Scholar 

  3. Davies T.F., Yeo P.P.B., Evered D.C., Clark F., Smith B.R., Hall R. Value of thyroid-stimulating antibody determinations in predicting short-term thyrotoxic relapse in Graves’ disease. Lancet 1: 1181, 1977.

    Article  PubMed  CAS  Google Scholar 

  4. Endo K., Kasagi K., Konishi J., Ikekubo K., Okuno T., Takeda Y., Mori T., Torizuka K. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves’disease and Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 46: 734, 1978.

    Article  PubMed  CAS  Google Scholar 

  5. O’Donnell J., Trokoudes K., Silverberg J., Row V., Volpe R. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves’ disease. J. Clin. Endocrinol. Metab. 46: 770, 1978.

    Article  PubMed  Google Scholar 

  6. Strakosch C.R., Joyner D., Wall J.R. Thyroid-stimulating antibodies in patients with auto-immune disorders. J. Clin. Endocrinol. Metab. 47: 361, 1978.

    Article  PubMed  CAS  Google Scholar 

  7. Fenzi G., Hashizume K., Roudebush C.P., DeGroot L.J. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. J. Clin. Endocrinol. Metab. 48: 572, 1979.

    Article  PubMed  CAS  Google Scholar 

  8. Kuzuya N., Chiu S.C., Ikeda H., Uchimura H., Ito K., Nagataki S. Correlation between thyroid stimulators and 3,5,3′-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin displacing activities. J. Clin. Endocrinol. Metab. 48: 706, 1979.

    Article  PubMed  CAS  Google Scholar 

  9. Teng C.S., Yeung R.T.T. Changes in thyroid-stimulating antibody activity in Graves’ disease treated with antithyroid drug and its relationship to relapse: A prospective study. J. Clin. Endocrinol. Metab. 50: 144, 1980.

    Article  PubMed  CAS  Google Scholar 

  10. Bliddal H., Kirkegaard C., Neilsen K.S., Friis T. Prognostic value of thyrotropin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid opthalmopathy. Acta Endocrinol. (Kbh.) 98: 364, 1981.

    CAS  Google Scholar 

  11. Nagataki S., Uchimura H., Matsuzaki F., Masuyama U. Comparison of the triiodothyronine suppression test by the twenty-minute and the twenty-four-hour thyroidal 131I uptake in patients receiving thionamide drugs. J. Clin. Endocrinol. Metab. 38: 255, 1974.

    Article  PubMed  CAS  Google Scholar 

  12. McLachlan S.M., Smith B.R., Petereen V.B., Davies T.F., Hall R. Thyroid-stimulating autoantibody production in vitro. Nature 270: 447, 1977.

    Article  PubMed  CAS  Google Scholar 

  13. Kendall-Taylor P., Knox A.J., Steel N.R., Atkinson S. Evidence that thyroid-stimulating antibody is produced in the thyroid gland. Lancet 1: 654, 1984.

    Article  PubMed  CAS  Google Scholar 

  14. Kriss J.P. Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lamda anti-sera. J. Clin. Endocrinol. 28: 1440, 1968.

    Article  CAS  Google Scholar 

  15. Clague R., Mukhtar E.D., Pyle G.A., Nutt J., Clark F., Scott M., Evered D., Smith B.R., Hall R. Thyroid stimulating immunoglobulins and the control of thyroid function. J. Clin. Endocrinol. Metab. 43: 550, 1976.

    Article  PubMed  CAS  Google Scholar 

  16. Solomon D.H., Chopra I.J., Chopra U., Smith F.J. Identification of subgroups of euthyroid Graves’ ophthalmopathy. N. Engl. J. Med. 296: 181, 1977.

    Article  PubMed  CAS  Google Scholar 

  17. Shishiba Y., Ozawa Y., Ohtsuki N., Shimizu T. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves’ immunoglpbulin Gs assessed in the mouse. J. Clin. Endocrinol. Metab. 54: 858, 1982.

    Article  PubMed  CAS  Google Scholar 

  18. Ealey P.A., Valente W.A., Ekins R.P., Kohn L.D., Marshall N.J. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. Endocrinology 116: 124, 1984.

    Article  Google Scholar 

  19. Sugenoya A., Kidd A., Trokoudes K., Row V.V., Volpe R. Correlation between thyrotropin displacing activity (TDA) and human thyroid stimulating activity (TSA) by immunoglobulins from patients with Graves’ disease and other thyroid disorders. J. Clin. Endocrinol. Metab. 48: 398, 1979.

    Article  PubMed  CAS  Google Scholar 

  20. Macchia E., Fenzi G.F., Monzani F., Lippi F., Vitti P., Grasso L., Bartalena L., Baschieri L., Pinchera A. Comparison between thyroid stimulating and TSH-binding inhibiting immunoglobulins of Graves’ disease. Clin. Endocrinol. (Oxf.) 15: 175, 1981.

    Article  CAS  Google Scholar 

  21. Hardisty C.A., Kendal-Taylor P., Atkinson S., Hamphries H., Hunro D.S. The assay of Graves’ immunoglobulins: a comparison of different methods. Clin. Endocrinol. (Oxf.) 18: 677, 1983.

    Article  Google Scholar 

  22. Borges M., Ingbar J.C., Endo K., Amir S., Uchimura H., Nagataki S., Ingbar S.H. A new method for assessing the thyrotropin binding inhibitory activity in the immunoglobulins and whole serum of patients with Graves’ disease. J. Clin. Endocrinol. Metab. 54: 552, 1982.

    Article  PubMed  CAS  Google Scholar 

  23. Bliddal H., Bech K., Petersen P.H., Siersbaek-Nielsen K., Friis T. Evidence of a correlation between thyrotrophin receptor binding inhibition and thyroid adenylate cyclase activation by immunoglobulins in Graves’ disease before and during long-term antithyroid treatment. Acta Endocrinol. (Kbh.) 101: 35, 1982.

    CAS  Google Scholar 

  24. Biro J. Thyroid-stimulating antibodies in Graves’ disease and the effect of thyrotrophin-binding globulins on their determination. J. Endocrinol. 92: 175, 1982.

    Article  PubMed  CAS  Google Scholar 

  25. Hensen J., Kotula P., Finke R., Bogner U., Badenhoop K. Methodological aspects and clinical results of an assay for thyroid-stimulating antibodies: Correlation with thyrotropin binding-inhibiting antibodies. J. Clin. Endocrinol. Metab. 58: 980, 1984.

    Article  PubMed  CAS  Google Scholar 

  26. Valente W.A., Vitte P., Yavin Z., Yavin E., Retella C.M., Grollman E.F., Toccafondi R.S., Kohn L.D. Monoclonal antibodies to the thyrotropin receptor: Stimulating and blocking antibodies derived from the lympocytes of patients with Graves’ disease. Proc. Natl. Acad. Sci. (USA) 79: 6680, 1982.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. H. Uchimura

    Present address: University of California, Davis, School of Medicine, University of California, Davis, California, 95616, USA

Authors and Affiliations

  1. The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Hongo, Tokyo, 113, Japan

    H. Uchimura, N. Akimoto, T. Mitsuhashi, K. Kubota, N. Kuzuya, Y. Imai, H. Ikeda, F. Matsuzaki & L. F. Kumagai

Authors
  1. H. Uchimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Akimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Mitsuhashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Kubota
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Kuzuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y. Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F. Matsuzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. L. F. Kumagai
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uchimura, H., Akimoto, N., Mitsuhashi, T. et al. Changes in Thyrotropin Binding Inhibiting Immunoglobulins (TBII) in sera of patients with Graves’ disease at the time of relapse or exacerbation. J Endocrinol Invest 9, 37–42 (1986). https://doi.org/10.1007/BF03348060

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348060

Key-words

Search

Navigation